DelfaGLP-1 Atlas

Lead sponsor

University of Maryland, Baltimore

4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

4

Trials led

2

Active

703

Total enrollment

3

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
2
Phase 2
1
Not applicable
1

Trials by status

Recruiting
2
Terminated
1
Withdrawn
1

Trials led

PORTBMI ≥27Ph 1Recruiting600
Pharmacogenomics of GLP1 Receptor AgonistsBMI 18-40Ph 1Terminated63
STACBMI 20-50Ph 2Recruiting40
Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMBMI ≤52not applicableWithdrawnnot disclosed